Glyco-engineering for biopharmaceutical production in moss bioreactors

The production of recombinant biopharmaceuticals (pharmaceutical proteins) is a strongly growing area in the pharmaceutical industry. While most products to date are produced in mammalian cell cultures, namely CHO cells, plant-based production systems gained increasing acceptance over the last years...

Full description

Bibliographic Details
Main Authors: Eva L. Decker, Juliana eParsons, Ralf eReski
Format: Article
Language:English
Published: Frontiers Media S.A. 2014-07-01
Series:Frontiers in Plant Science
Subjects:
Online Access:http://journal.frontiersin.org/Journal/10.3389/fpls.2014.00346/full